VCAM1 and Schnyder corneal dystrophy: First, the improved microvascular blood circulation and reduced plasma VCAM-1 levels in patients treated with PPS may not be pertinent to the mechanisms that regulate pain in SCD patients or, at the least, may not be sufficient to reduce daily pain scores.